A large number of hepatobiliary abnormalities have? been described in assoc
iation with inflammatory bowel disease (IBD) including primary sclerosing c
holangitis (PSC), pericholangitis, chronic hepatitis, cryptogenic cirrhosis
, cholangiocarcinoma, and cholelithiasis. PSC is the most common of these h
epatobiliary diseases. This high degree of association with IBD suggests a
common pathogenic mechanism; however, no causal relationship has been estab
lished between the two conditions. Medical therapy has not proven successfu
l in slowing disease progression or prolonging survival. Endoscopic manipul
ation is recommended for treating complications of recurrent cholangitis or
worsening jaundice in the setting of a dominant stricture, but endoscopic
approaches have not been shown to improve survival or decrease the need for
liver transplantation.